GenoFocus Acquires Patent for the Oral Plaque-Fighting Enzyme Mutanase

GenoFocus is pleased to announce that we have acquired a patent for mutanase, an oral care enzyme designed to combat plaque. GF Mutanase is alpha 1,3-glucanase which has a specific oral plaque binding domain. Therefore, it can maintain its catalytic activity even after users rinse their mouths.

GenoFocus plans to promote GF Mutanase to the global market this year.

65, Techno 1-ro, Yuseong-gu, Daejeon 34014, South Korea| Tel : +82-42-862-4483 | Fax : +82-42-862-4484 | Email:
Copyright (c) 2017 GenoFocus. All rights reserved.